Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease

Fukagawa M, Komaba H. Chronic kidney disease-mineral and bone disorder in Asia. Kidney Dis (Basel). 2017;3(1):1–7. https://doi.org/10.1159/000470909.

Article  PubMed  Google Scholar 

Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016;9(4):583–91. https://doi.org/10.1093/ckj/sfw047.

Article  PubMed  PubMed Central  Google Scholar 

Shroff R, Wesseling-Perry K, Bacchetta J. Chronic kidney disease – mineral and bone disorder (CKD-MBD). In: Emma F, Goldstein SL, Bagga A, Bates CM, Shroff R, editors. Pediatric Nephrology. Berlin: Springer; 2002. pp. 1755–83. https://doi.org/10.1007/978-3-030-52719-8_129.

Chapter  Google Scholar 

Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M, et al. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; a post-hoc analysis of a randomized clinical trial. PLoS ONE. 2018;13(10):e0205831. https://doi.org/10.1371/journal.pone.0205831.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lalayiannis AD, Crabtree NJ, Ferro CJ, Wheeler DC, Duncan ND, Smith C, et al. Bone mineral density and vascular calcification in children and young adults with CKD 4 to 5 or on dialysis. Kidney Int Rep. 2022;8(2):265–73. https://doi.org/10.1016/j.ekir.2022.10.023.

Article  PubMed  PubMed Central  Google Scholar 

Lawal OM, Balogun MO, Akintomide AO, Ayoola OO, Mene-Afejuku TO, Ogunlade O, et al. Carotid intima-media thickness: a surrogate marker for cardiovascular disease in chronic kidney disease patients. Clin Med Insights Cardiol. 2019;13:1179546819852941. https://doi.org/10.1177/1179546819852941.

Article  PubMed  PubMed Central  Google Scholar 

Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, et al. Cardiovascular phenotypes in children with CKD: the 4 C study. Clin J Am Soc Nephrol. 2017;12(1):19–28. https://doi.org/10.2215/CJN.01090216.

Article  PubMed  Google Scholar 

Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, et al. Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol. 2012;7(12):1930–7. https://doi.org/10.2215/CJN.03130312.

Article  PubMed  PubMed Central  Google Scholar 

Lopes R, Morais MB, Oliveira FLC, Brecheret AP, Abreu ALCS, Andrade MC. Evaluation of carotid intima-media thickness and factors associated with cardiovascular disease in children and adolescents with chronic kidney disease. J Pediatr (Rio J). 2019 Nov-Dec;95(6):696–704. https://doi.org/10.1016/j.jped.2018.06.010.

Husen M, Fischer A, Lehnhardt A, Klaassen I, Moller K, Muller-Wiefel D, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010;78(2):200–6. https://doi.org/10.1038/ki.2010.107.

Article  CAS  PubMed  Google Scholar 

Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79(12):1370–8. https://doi.org/10.1038/ki.2011.47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palupi-Baroto R, Hermawan K, Murni IK, Nurlitasari T, Prihastuti Y, Sekali DRK, et al. High fibroblast growth factor 23 as a biomarker for severe cardiac impairment in children with chronic kidney disease: a single tertiary center study. Int J Nephrol Renovasc Dis. 2021;14:165–71. https://doi.org/10.2147/IJNRD.S304143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naveh-Many T, Silver J. The pas de trois of vitamin D, FGF23, and PTH. J Am Soc Nephrol. 2017;28(2):393–5. https://doi.org/10.1681/ASN.2016090944.

Article  CAS  PubMed  Google Scholar 

Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013;9(11):641–9. https://doi.org/10.1038/nrneph.2013.147.

Article  CAS  PubMed  Google Scholar 

Albanese L, Caliendo G, D’Elia G, Passariello L, Molinari AM, Napoli C, et al. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. J Circ Biomark. 2022;11:1–4. https://doi.org/10.33393/jcb.2022.2328.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurpas A, Supeł K, Idzikowska K, Zielińska M. FGF23: a review of its role in mineral metabolism and renal and cardiovascular disease. Dis Markers. 2021;2021:8821292. https://doi.org/10.1155/2021/8821292.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab. 2009;94(2):511–7. https://doi.org/10.1210/jc.2008-0326.

Article  CAS  PubMed  Google Scholar 

Leifheit-Nestler M, Haffner D. How FGF23 shapes multiple organs in chronic kidney disease. Mol Cell Pediatr. 2021;8(1):12. https://doi.org/10.1186/s40348-021-00123-x.

Article  PubMed  PubMed Central  Google Scholar 

Hanudel MR, Salusky IB. Treatment of pediatric chronic kidney disease-mineral and bone disorder. Curr Osteoporos Rep. 2017;15(3):198–206. https://doi.org/10.1007/s11914-017-0365-0.

Article  PubMed  PubMed Central  Google Scholar 

Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012;7(1):146–52. https://doi.org/10.2215/CJN.05940611.

Article  CAS  PubMed  Google Scholar 

Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011;26(6):945–51. https://doi.org/10.1007/s00467-011-1822-0.

Article  PubMed  Google Scholar 

Singh G, Mishra OP, Abhinay A, Agarwal V, Mishra SP, Dwivedi AD, et al. Fibroblast growth factor 23 level and cardiovascular parameters in children with chronic kidney disease. Indian J Pediatr. 2022;89(9):865–71. https://doi.org/10.1007/s12098-021-03927-x.

Article  PubMed  Google Scholar 

Preka E, Ranchin B, Doyon A, Vierge M, Ginhoux T, Kassai B, et al. The interplay between bone and vessels in pediatric CKD: lessons from a single-center study. Pediatr Nephrol. 2018;33(9):1565–75. https://doi.org/10.1007/s00467-018-3978-3.

Article  PubMed  Google Scholar 

KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements. 2013;3:1–150. https://doi.org/10.1038/kisup.2012.77.

Article  Google Scholar 

KDIGO Executive Committee. KDIGO 2023 clinical practice guideline for the evaluation and management of chronic kidney disease.

Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. https://doi.org/10.1542/peds.2017-1904.

Article  PubMed  Google Scholar 

Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, et al. Fibroblast growth factor 23 and risk of CKD progression in children. Clin J Am Soc Nephrol. 2016;11(11):1989–98. https://doi.org/10.2215/CJN.02110216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jančič SG, Močnik M, Marčun Varda N. Glomerular filtration rate assessment in children. Child (Basel). 2022;9(12):1995. https://doi.org/10.3390/children9121995.

Article  Google Scholar 

Drole Torkar A, Plesnik E, Groselj U, Battelino T, Kotnik P. Carotid intima-media thickness in healthy children and adolescents: normative data and systematic literature review. Front Cardiovasc Med. 2020;7:597768. https://doi.org/10.3389/fcvm.2020.597768.

Article  PubMed  PubMed Central  Google Scholar 

Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–quiz111189. https://doi.org/10.1016/j.echo.2007.11.011.

Article  PubMed 

留言 (0)

沒有登入
gif